The serum levels of AST, ALT, ALP, LDH, and GGT, which were elevated due to STZ-induced diabetes, showed a significant dose-dependent reduction in the BCS-treated groups (50, 100, and 200 mg/kg) (p < 0.01) (Table 10). The gene discussed is GPT; the disease is diabetes mellitus.